28341-54-0

Usage

InChI:InChI=1/C10H11NO5/c12-10(13)2-1-7-16-9-5-3-8(4-6-9)11(14)15/h3-6H,1-2,7H2,(H,12,13)

Upstream product

• 56-23-5 tetrachloromethane 
• 2453-49-8 2-iminotetrahydrofuran hydrochloride 
• 63867-13-0 4-(N,N-diethylamino)butanoic acid 
• 99072-20-5 4-(4-nitrophenoxy)butanenitrile 
• 96-48-0 4-butanolide 
• 824-78-2 4-nitrophenol sodium salt 
• 70-18-8 GLUTATHIONE 
• 625-38-7 but-3-enoic acid 
• 7664-93-9 sulfuric acid 
• 627-00-9 γ-chlorobutyric acid 
• 110-63-4 Butane-1,4-diol 
• 3153-37-5 methyl 4-chlorobutyrate 
• 2969-81-5 Ethyl 4-bromobutyrate 
• 3153-36-4 4-chloro-butyric acid ethyl ester 

Downstream Products

• 91092-88-5 1-furfuryloxy-4-nitro-benzene 
• 1085-40-1 phosphorous acid diethyl ester-(4-nitro-phenyl ester) 
• 92033-76-6 1-[2-(1-piperidinyl)ethoxy]4-nitrobenzene 
• 129199-42-4 2-(4-nitrophenoxy)-5-nitropyridine 
• 14467-60-8 1,5-Bis(4-nitrophenoxy)pentane 
• 10572-16-4 3-(4-nitrophenoxy)propanoic acid 
• 71790-86-8 ethyl p-nitrophenyl chloromethylphosphonate 
• 904-10-9 N-[3-(4-Nitrophenoxy)propyl]phthalimide 
• 99072-20-5 4-(4-nitrophenoxy)butanenitrile 
• 99072-46-5 dimethyl-oxalamic acid-(4-nitro-phenyl ester) 
• 2591-57-3 O-ethyl O-methyl O-p-nitrophenylthiophosphate 
• 7508-73-8 O-ethyl O,O-di(4-nitrophenyl)thiophosphate 
• 123974-61-8 1-nitro-4-(n-octadecyloxy)benzene 
• 107682-77-9 phosphoric acid-(2-chloro-ethyl ester)-bis-(4-nitro-phenyl ester) 

Relevant academic research and scientific papers

Design, synthesis, and biological evaluation of 3-amino-2-oxazolidinone derivatives as potent quorum-sensing inhibitors of Pseudomonas aeruginosa PAO1

Due to the increasing resistance of Pseudomonas aeruginosa to most clinically relevant antimicrobials, it is challenging to treat bacterial infection with traditional antibiotics. Quorum sensing can regulate the production of biofilms and virulence factors which are closely related to bacterial resistance. Previously we synthesized a series of oxazolidinone compounds targeting the quorum-sensing transcriptional regulatory protein CviR and ZS-12 showed good activity against Chromobacterium violaceum CV026 quorum-sensing. In this study, eighteen 3-amino-2-oxazolidinone compounds were designed and synthesized using ZS-12 as the lead compound. We initially evaluated the inhibitory activities of novel oxazolidinone compounds against QS using C. violaceum CV026 as a reporter strain. Thirteen compounds showed good activities (IC50 range 3.69–63.58 μM) and YXL-13 inhibition was the most significant (IC50 = 3.686 ± 0.5790 μM) against biofilm formation and virulence factors determination of P. aeruginosa PAO1. In vitro, YXL-13 significantly inhibited the formation of PAO1 biofilm (range 42.98%–17.67%), the production of virulence factors (pyocyanin, elastase, rhamnolipid, and protease), and bacterial motility. Moreover, the combination of YXL-13 with an antibiotic (meropenem trihydrate) could significantly improve the antibiotic susceptibility of biofilm P. aeruginosa PAO1 cells. In vivo, YXL-13 significantly prolonged the lifespan of wildtype Caenorhabditis elegans N2 infected by P. aeruginosa PAO1. In conclusion, YXL-13 is a candidate agent for antibiotic-resistant P. aeruginosa PAO1and provides a method for finding new antibacterial drugs.

Identification of 5-Substituted 2-Acylaminothiazoles That Activate Tat-Mediated Transcription in HIV-1 Latency Models

The persistent reservoir of cells latently infected with human immunodeficiency virus (HIV)-integrated proviral DNA necessitates lifelong suppressive antiretroviral therapy (ART). Epigenetic targeted compounds have shown promise as potential latency-reversing agents; however, these drugs have undesirable toxicity and lack specificity for HIV. We utilized a novel HEK293-derived FlpIn dual-reporter cell line, which quantifies specific HIV provirus reactivation (LTR promoter) relative to nonspecific host cell gene expression (CMV promoter), to identify the 5-substituted 2-acylaminothiazole hit class. Here, we describe the optimization of the hit class, defining the functionality necessary for HIV gene activation and for improving in vitro metabolism and solubility. The optimized compounds displayed enhanced HIV gene expression in HEK293 and Jurkat 10.6 latency cellular models and increased unspliced HIV RNA in resting CD4+ T cells isolated from HIV-infected individuals on ART, demonstrating the potential of the 2-acylaminothiazole class as latency-reversing agents.

POLYCONJUGATES FOR DELIVERY OF RNAI TRIGGERS TO TUMOR CELLS IN VIVO

The present invention is directed compositions for delivery of RNA interference (RNAi) triggers to integrin positive tumor cells in vivo. The compositions comprise RGD ligand- targeted amphipathic membrane active polyamines reversibly modified with enzyme cleavable dipeptide-amidobenzyl-carbonate masking agents. Modification masks membrane activity of the polymer while reversibility provides physiological responsiveness. The reversibly modified polyamines (dynamic polyconjugate or conjugate) are further covalently linked to an RNAi trigger.

The discovery and optimization of novel dual inhibitors of topoisomerase ii and histone deacetylase

A novel class of podophyllotoxin derivatives have been designed and synthesized based on the synergistic antitumor effects of topoisomerase II and histone deacetylase inhibitors. Their inhibitory activities towards histone deacetylases and Topo II and their cytotoxicities in cancer cell lines were evaluated. The aromatic capping group connection, linker length and zinc-binding group were systematically varied and preliminary conclusions regarding structure-activity relationships are discussed. Among all of the synthesized hybrid compounds, compound 24d showed the most potent HDAC inhibitory activity at a low nanomolar level and exhibited powerful antiproliferative activity towards HCT116 colon carcinoma cells at a low micromolar level. Further exploration of this series led to the discovery of potent dual inhibitor 32, which exhibited the strongest in vitro cytotoxic activity.